• Info
  • Insider Ownership

Insider Trading & Ownership of Robert E. Abernathy

Location
Boston, MA
Summary
The estimated net worth of Robert E. Abernathy is at least $3,140,642 dollars as of 02 Apr 2026. Robert E. Abernathy is the Director of HAEMONETICS CORP and owns shares of HAEMONETICS CORP (HAE) stock worth about $1.86M. Robert E. Abernathy is the Director of AVIENT CORP and owns shares of AVIENT CORP (AVNT) stock worth about $1.28M.
Signature
/s/ Robert K. James, Power of Attorney for Robert E. Abernathy
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Robert E. Abernathy and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • Robert E. Abernathy has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $3,140,642.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: HAEMONETICS CORP ($1,863,832).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Robert E. Abernathy

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
HAE HAEMONETICS CORP Director $1,863,832 24 Jul 2025
AVNT AVIENT CORP Director $1,276,810 31 Mar 2026

Insider Transactions Reported by Robert E. Abernathy:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored